Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Parcel Service
UPS
|
+$428M |
| 2 |
DexCom
DXCM
|
+$384M |
| 3 |
WIX.com
WIX
|
+$359M |
| 4 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$254M |
| 5 |
Caesars Entertainment
CZR
|
+$246M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.14B |
| 2 |
Microchip Technology
MCHP
|
+$535M |
| 3 |
Merck
MRK
|
+$512M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$444M |
| 5 |
Illumina
ILMN
|
+$413M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.59% |
| 2 | Healthcare | 18.35% |
| 3 | Consumer Discretionary | 11.3% |
| 4 | Financials | 10.45% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Morningstar
MORN
$7.38B
| $4.65M | ﹤0.01% |
18,086
+10,374
| +135% | +$2.52M |
|
1077
Nasdaq
NDAQ
$53.6B
| $4.63M | ﹤0.01% |
79,053
-12,321
| -13% | -$678K |
|
1078
Qualys
QLYS
$4.78B
| $4.61M | ﹤0.01% |
45,804
+33,924
| +286% | +$3.45M |
|
1079
Vertiv
VRT
$104B
| $4.58M | ﹤0.01% |
167,668
+116,371
| +227% | +$2.78M |
|
1080
Realty Income
O
$61.3B
| $4.57M | ﹤0.01% |
70,659
-68,027
| -49% | -$4.47M |
|
1081
Curis
CRIS
$9.41M
| $4.49M | ﹤0.01% |
+1,391
| New | +$6.28M |
|
1082
Packaging Corp of America
PKG
$22.6B
| $4.49M | ﹤0.01% |
33,139
-19,983
| -38% | -$2.87M |
|
|
AFMD
1083
DELISTED
Affimed
AFMD
| $4.47M | ﹤0.01% |
+52,671
| New | +$4.81M |
|
1084
Ardelyx
ARDX
$1.26B
| $4.42M | ﹤0.01% |
582,867
+40,616
| +7% | +$300K |
|
|
MNRL
1085
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $4.41M | ﹤0.01% |
207,055
+5,709
| +3% | +$104K |
|
1086
Paymentus
PAY
$4.29B
| $4.4M | ﹤0.01% |
+123,958
| New | +$3.87M |
|
1087
Fulgent Genetics
FLGT
$558M
| $4.39M | ﹤0.01% |
+47,645
| New | +$3.8M |
|
1088
Pacira BioSciences
PCRX
$1.05B
| $4.39M | ﹤0.01% |
72,334
-4,981
| -6% | -$315K |
|
|
NBIS
1089
Nebius Group N.V.
NBIS
$43.1B
| $4.38M | ﹤0.01% |
61,903
-110,685
| -64% | -$7.26M |
|
1090
Baker Hughes
BKR
$58B
| $4.34M | ﹤0.01% |
189,651
+50,127
| +36% | +$1.16M |
|
1091
Albemarle
ALB
$13.3B
| $4.33M | ﹤0.01% |
25,711
-44,761
| -64% | -$7.22M |
|
1092
Rogers Communications
RCI
$18.8B
| $4.3M | ﹤0.01% |
80,842
-22,582
| -22% | -$1.14M |
|
1093
Fortive
FTV
$19.5B
| $4.29M | ﹤0.01% |
81,555
-5,224
| -6% | -$282K |
|
1094
Restaurant Brands International
QSR
$26B
| $4.24M | ﹤0.01% |
65,754
+3,004
| +5% | +$202K |
|
|
NUAN
1095
DELISTED
Nuance Communications, Inc.
NUAN
| $4.23M | ﹤0.01% |
77,678
-122,894
| -61% | -$6.48M |
|
1096
Corcept Therapeutics
CORT
$10.1B
| $4.22M | ﹤0.01% |
191,618
-28,740
| -13% | -$640K |
|
1097
SPS Commerce
SPSC
$2.51B
| $4.19M | ﹤0.01% |
41,972
-2,650
| -6% | -$262K |
|
|
SGI
1098
Somnigroup International
SGI
$15.2B
| $4.19M | ﹤0.01% |
106,909
-5,414
| -5% | -$207K |
|
|
VNET
1099
VNET Group
VNET
$1.92B
| $4.18M | ﹤0.01% |
181,908
+64,743
| +55% | +$1.65M |
|
|
CNST
1100
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $4.16M | ﹤0.01% |
+122,901
| New | +$3.13M |
|
Similar funds
Janus Henderson Group's Q2 2021 Portfolio in Review
As of Q2 2021, Janus Henderson Group held 1,725 positions worth $234B, up 6.7% from $219B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2021 filing shows 172 new, 741 increased, 667 reduced and 123 closed positions. Its largest new stake was Centessa Pharmaceuticals: 5,680,933 shares worth $120M. The largest sale was Apple, an estimated $1.14B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2021 buy was Centessa Pharmaceuticals: 5,680,933 shares worth $120M.
- Janus Henderson Group added most to United Parcel Service in Q2 2021, an estimated $428M increase.
- Janus Henderson Group's biggest Q2 2021 reduction was Apple, cutting an estimated $1.14B.
- Janus Henderson Group fully exited PRA Health Sciences, Inc. in Q2 2021, selling an estimated $368M.
- Janus Henderson Group's ten largest holdings make up 23% of its $234B portfolio in Q2 2021.
- Janus Henderson Group opened 172 new positions and closed 123 in Q2 2021.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $234B.
Based on Janus Henderson Group's 13F filing for Q2 2021, filed 16 Aug 2021.